These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 22920170

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Target therapy for hepatocellular carcinoma: is sorafenib for everybody?
    Daniele B, Di Maio M.
    J Clin Gastroenterol; 2009; 43(5):389-90. PubMed ID: 19564813
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sorafenib in advanced hepatocellular carcinoma.
    Spinzi G, Paggi S.
    N Engl J Med; 2008 Dec 04; 359(23):2497-8; author reply 2498-9. PubMed ID: 19052134
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sorafenib in hepatocellular carcinoma.
    Josephs DH, Ross PJ.
    Br J Hosp Med (Lond); 2010 Aug 04; 71(8):451-6. PubMed ID: 20852487
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sorafenib in advanced hepatocellular carcinoma.
    Palmer DH.
    N Engl J Med; 2008 Dec 04; 359(23):2498; author reply 2498-9. PubMed ID: 19065750
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Invasive squamous cell carcinoma and sorafenib in a black patient.
    Donaldson MR, Stetson CL, Smith JL.
    Arch Dermatol; 2011 Jan 04; 147(1):133-4. PubMed ID: 21242415
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatocellular carcinoma: The beginning of a long journey.
    Cascinu S.
    Dig Liver Dis; 2009 Oct 04; 41(10):707-8. PubMed ID: 19699696
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib.
    Alexandrescu DT, McClure R, Farzanmehr H, Dasanu CA.
    J Clin Oncol; 2008 Aug 20; 26(24):4047-8. PubMed ID: 18711201
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.